Current Issue 2019  Archive 2018  2017 

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.


The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.


Editor-in-Chief of Journal of Energy and Power Technology

Zhao Yang DongZhao Yang Dong (M’99–SM’06-F'17) obtained Ph.D. degree from the University of Sydney, Australia in 1999. He is currently the SHARP professor and Director of the University of New South Wales Digital Grid Futures Institute, The University of New South Wales, Australia. He is also Director for ARC Research Hub for Integrated Energy Storage Solutions. He was previously Professor and Head of School of Electrical and Information Engineering, University of Sydney, and Ausgrid Chair and Director of the Ausgrid Centre for Intelligent Electricity Networks, the University of Newcastle, Australia. He also held industrial positions with Transend Networks (now TAS Networks), Australia. His research interests include smart grid, power system planning, power system security, renewable energy systems, electricity market, load modelling, and computational intelligence and its application in power engineering. He is serving/served as an editor of IEEE Transactions on Smart Grid, IEEE Power Engineering Letters, and IET Renewable Power Generation.HE is Fellow of IEEE.

Special Issue

Living Donor Liver Transplantation: Worldwide Evolution and Unmet Need

Submission Deadline: July 30, 2018 (Open)                Submit Now

Guest Editor

Dimitrios E. Giakoustidis, MD, PhD
Associate Professor of Surgery and Transplantation, Division of Transplant Surgery, Department of Surgery, Aristotle University, Hippokration General Hospital Thessaloniki, Greece
E-Mail: [email protected]
Research Interests: surgical oncology; liver surgery; liver transplantation; pancreatic cancer; hcc and hcc signaling, etc


Luca Toti, MD, PhD
Assistant Professor of Surgery and Transplantation, Department of Experimental Medicine and Surgery, Section of Transplantation, University of Rome Tor Vergata, Rome, Italy
E-Mail: [email protected]

Naimish N. Mehta, MD, PhD
Chief Liver Transplant Surgeon, Senior Consultant G.I & HPB Surgery, Convenor Gyan Burman Hepato-Biliary Fellowship, R. No. 2222, Department of Surgical GI & Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India
E-Mail: [email protected]

About This Topic

Shortage of cadaveric donors represents a major obstacle to liver transplantation worldwide. Furthermore, the number of patients being listed for this procedure is increasing, while the number of donors remains stable. Consequently, more and more patients are dying while still on the waiting list.

Living donor liver transplantation (LDLT) is performed in both adults and children. Adult-to-adult LDLT has been developed and established primarily in Asian countries. Given the comparatively greater availability of deceased donors in Western countries, LDLT comprises a much lower percentage of transplantations compared with that in Asian countries. This has a significant impact on recipients who are currently disadvantaged by the Model for End-Stage Liver Disease (MELD)-based system of liver allocation and in some countries, the low percentage of deceased donors.

In recent years, there have been significant advances in surgical techniques. Laparoscopic or robotic harvesting of the liver, dual grafts, vein reconstruction, enhanced recovery protocols, and intra-operative bleeding control, are important issues in the field of liver transplantation. Improvements in immunosuppression, novel anti-hepatitis C drugs and hepatocellular carcinoma-targeted therapies could improve the outcome and survival of transplanted patients.

In this special issue, we welcome manuscripts concerning all current and novel knowledge in the field of living donor liver transplantation.

Planned Papers

Title: Liver LRD Transplants
Author: Wayel Jassem